Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

label:2813 (Glytoucan)

Id:7e952419-8440-5933-9089-f0e7f79e8564

Glytoucan:G23345GE

Results found

Linked to

	Label	Description
	label:2813 has canonical residue n-glycan core d-glcnac a Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOSYLATION.SITE:SITE00050498 CUI has saccharide label:2813 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2813 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000005 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2813 has canonical residue n-glycan b-d-galp 3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2813 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000016 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2813 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000019 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2813 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000013 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2813 has glycosequence GLYGEN.GLYCOSEQUENCE:G03895SR-GLYCOSEQ00054796 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2813 has glycosequence GLYGEN.GLYCOSEQUENCE:G03895SR-GLYCOSEQ00054793 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2813 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000025 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2813 has canonical residue n-glycan core d-glcnac a

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOSYLATION.SITE:SITE00050498 CUI has saccharide label:2813

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2813 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000005 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2813 has canonical residue n-glycan b-d-galp 3

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2813 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000016 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2813 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000019 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2813 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000013 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2813 has glycosequence GLYGEN.GLYCOSEQUENCE:G03895SR-GLYCOSEQ00054796 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2813 has glycosequence GLYGEN.GLYCOSEQUENCE:G03895SR-GLYCOSEQ00054793 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2813 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000025 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.